Clinical Trials on Autosomal Recessive Polycystic Kidney Disease in Belgium

Total 388 results

Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Autosomal Recessive Polycystic Kidney (ARPKD)

United States, United Kingdom, Belgium, Poland, France, Germany, Italy
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Autosomal Recessive Polycystic Kidney Disease (ARPKD)

United States, Belgium, Spain, Germany, United Kingdom, Poland
Andreas L. Serra

Unknown

The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe

Autosomal Dominant Polycystic Kidney Disease

France, Switzerland, Germany, Netherlands, Belgium, Czech Republic, Italy, Spain, Turkey, United Kingdom
Otsuka Pharmaceutical Europe Ltd

Unknown

A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe (ACQUIRE)

Autosomal Dominant Polycystic Kidney Disease

Spain, United Kingdom, Germany, France, Belgium, Switzerland, Austria
Galapagos NV

Terminated

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease

Belgium, Netherlands, Italy, Spain, Czechia, Germany, Poland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Germany, Italy, Belgium, United Kingdom
Sanofi

Terminated

Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat (STAGED-PKD-EXT)

Congenital Cystic Kidney Disease

Germany, Spain, United States, Australia, Belgium, Japan, Korea, Republic of, Netherlands
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (TEMPO3:4)

Polycystic Kidney Disease, Autosomal Dominant

United States, Belgium, United Kingdom, Russian Federation, France, Australia, Netherlands, Italy, Japan, Denmark, Romania, Poland, Canada, Argentina, Germany
Radboud University Medical Center
Ipsen

Completed

Lanreotide as Treatment of Polycystic Livers (LOCKCYST)

Liver Diseases | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver Disease

Netherlands, Belgium
Otsuka Pharmaceutical Development & Commercialization...

Completed

Tolvaptan Extension Study in Participants With ADPKD (TEMPO 4/4)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease (OVERTURE)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Chronic Kidney Disease | Autosomal Dominant Polycystic Kidney Disease

Australia, Belgium, Italy, Spain, Sweden, United States, Canada, Netherlands, Czechia, Poland, Germany, Russian Federation, Hungary, Israel, Puerto Rico, Argentina, Denmark, South Africa, United Kingdom, Norway, France, Romania
Genzyme, a Sanofi Company

Terminated

A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients (STAGED-PKD)

Polycystic Kidney, Autosomal Dominant

Belgium, Germany, Czechia, United States, Italy, Poland, Argentina, Australia, Austria, Canada, China, Denmark, France, Israel, Japan, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Taiwan, Turkey, United Kingdom
Radboud University Medical Center
Ipsen

Unknown

Open-Label Extension of LOCKCYST Trial (LOCKCYST-ext)

Liver Diseases | Hepatomegaly | Polycystic Liver Disease | Polycystic Kidney | Autosomal Dominant

Netherlands, Belgium
Reata, a wholly owned subsidiary of Biogen

Terminated

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (FALCON)

Autosomal Dominant Polycystic Kidney | ADPKD

United States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
Otsuka Pharmaceutical Development & Commercialization...

Completed

Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney, Autosomal Dominant

Belgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
University Medical Center Groningen

Not yet recruiting

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life (HYDRO-PROTECT)

ADPKD

Netherlands, United Kingdom, Belgium, Germany, France, Spain
Centre Hospitalier Universitaire de Liege

Recruiting

Free Gingival Graft Versus Connective Tissue Graft

Gingival Recession | Gingival Recession, Localized

Belgium
European Society of Intensive Care Medicine

Completed

PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy (PEACE)

Acute Kidney Injury | Renal Replacement Therapy | Chronic End Stage Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Multidisciplinary Care for Patients With Chronic Kidney Disease to Increase Their Self-management.

Chronic Kidney Diseases

Belgium
Universitair Ziekenhuis Brussel

Terminated

Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program

Polycystic Ovarian Syndrome | Infertility, Female | Lifestyle

Belgium
Universitaire Ziekenhuizen KU Leuven
Ipsen

Completed

Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease (LOCKCYST)

Polycystic Liver Disease

Belgium
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Completed

Nephrocare mHealth Project: Telemonitoring of Blood Pressure (Nephrocare)

Chronic Kidney Diseases | Blood Pressure

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis (UToPaed_2)

Chronic Kidney Disease

Belgium
University Hospital, Ghent

Completed

Uremic Toxins of Patients With Acute Kidney Failure

Kidney Failure, Acute

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Interventional Study (UToPaed_3)

Chronic Kidney Disease

Belgium
EXcorLab GmbH
Nipro Europe N.V.

Completed

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Chronic Kidney Disease

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Observational Study (UToPaed_1)

Chronic Kidney Disease

Belgium
Universiteit Antwerpen

Completed

ENdothelial DysfUnction in Renal Disease and Exercise Training (Endure)

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients

Chronic Kidney Disease

Belgium
University Hospital, Ghent

Withdrawn

Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

Kidney Failure, Acute

Belgium
Université Catholique de Louvain

Unknown

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism (CYRANO)

Kidney Diseases

Belgium
University Hospital, Ghent

Completed

The Use of Low Molecular Weight Heparin in Hemodiafiltration

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Suspended

Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function

Chronic Kidney Disease

Belgium
Universitair Ziekenhuis Brussel

Completed

Non- Clinical Coagulation Activation During Hemodialysis (NC-Coact)

Kidney Diseases | End Stage Renal Disease | Hemodialysis Complication

Belgium
Universitaire Ziekenhuizen KU Leuven
Bristol-Myers Squibb

Completed

Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

ESRD | Anticoagulant Toxicity

Belgium
AZ Sint-Jan AV
Pfizer

Completed

13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients

Chronic Kidney Failure

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

CITrate and Evodial for Effective Dialysis (CITED) Study (CITED)

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Diurnal Variation of Uremic Solutes in Peritoneal Dialysis

Chronic Kidney Disease

Belgium
University Hospital, Ghent

Withdrawn

Early Goal Directed Therapy for Acute Kidney Injury

Kidney Injury, Acute

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Intestinal Transport of Microbial Metabolites in Chronic Kidney Disease

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis (INVEST-PD)

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

AXOS and Microbial Metabolites in CKD

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Inulin and Protein Fermentation in Hemodialysis Patients

Chronic Kidney Disease

Belgium
University Hospital, Ghent
University Ghent

Completed

Antibiotic Dosing in Patients on Intermittent Hemodialysis

Hemodialysis | Kidney Failure, Chronic | Antibiotics

Belgium
Universitair Ziekenhuis Brussel

Completed

Hemodialysis Adequacy Using a Heparin-grafted Dialyzer and a Citrate-enriched Dialysate (EvoCit-HD)

Kidney Diseases | End Stage Renal Disease | Hemodialysis Complication

Belgium
Universitair Ziekenhuis Brussel
UMC Utrecht; University Hospital, Antwerp; Imelda Hospital, Bonheiden; Cliniques... and other collaborators

Recruiting

Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT) (PREDICT)

End-stage Kidney Disease

Belgium, Netherlands
Universitaire Ziekenhuizen KU Leuven

Completed

Resistive Index Measurements After Kidney Transplantation

Kidney Failure

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

The Role of P-cresol and Related Protein Fermentation Metabolites in Chronic Kidney Disease Patients

Chronic Kidney Disease

Belgium

Clinical Trials on Autosomal Recessive Polycystic Kidney Disease in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations